DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sandimmune (Cyclosporine) - Adverse Event Reports - Other Serious Reactions

 



Index of reports > Cases resulting in other serious reactions (89)

     Convulsion (20)Depressed Level of Consciousness (12)Pain in Extremity (10)Pyrexia (10)Thrombotic Microangiopathy (10)Neurological Symptom (10)Graft Versus Host Disease (9)Renal Impairment (9)Rash (8)Renal Failure (8)

Below is the selection of adverse event reports related to Sandimmune (Cyclosporine) that includes cases resulting in other serious reactions.

 Reports 1 - 25 of 89   Next >>

Adverse event in 48 year old female receiving Sandimmune (Cyclosporine)

Reported by a physician from Japan on 2007-10-31

Patient: 48 year old female

Adverse reactions / side effects: RED Blood Cell Schistocytes Present, Acute Graft Versus Host Disease, RED Blood Cell Abnormality, Pulmonary Alveolar Haemorrhage, Blood Lactate Dehydrogenase Increased, Thrombotic Microangiopathy, Herpes Zoster, Multi-Organ Failure, Reticulocyte Count Increased, Respiratory Failure, Acute Respiratory Distress Syndrome, Haemolytic Anaemia, Thrombocytopenia

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Sandimmune (Cyclosporine)



Adverse event in 46 year old female receiving Sandimmune (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-10-29

Patient: 46 year old female

Adverse reactions / side effects: Cytomegalovirus Antigen Positive, Haptoglobin Decreased, RED Blood Cell Abnormality, Proteinuria, Blood Lactate Dehydrogenase Increased, Thrombotic Microangiopathy, Focal Glomerulosclerosis

Adverse event resulted in: disablity

Suspect drug(s):
Cyclophosphamide

Neoral
    Dosage: unk, unk
    Administration route: Oral
    Indication: Allogenic Bone Marrow Transplantation Therapy
    End date: 2007-03-22

Sandimmune
    Dosage: 3 mg/kg/day
    Indication: Allogenic Bone Marrow Transplantation Therapy
    Start date: 2006-12-12

Other drugs received by patient: Methotrexate; Campath; Fludarabine Phosphate



Adverse event in 46 year old female receiving Sandimmune (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-10-29

Patient: 46 year old female

Adverse reactions / side effects: Cytomegalovirus Antigen Positive, Haptoglobin Decreased, RED Blood Cell Abnormality, Proteinuria, Blood Lactate Dehydrogenase Increased, Thrombotic Microangiopathy, Focal Glomerulosclerosis

Adverse event resulted in: disablity

Suspect drug(s):
Cyclophosphamide

Neoral
    Dosage: unk, unk
    Administration route: Oral
    Indication: Allogenic Bone Marrow Transplantation Therapy
    End date: 2007-03-22

Sandimmune
    Dosage: 3 mg/kg/day
    Indication: Allogenic Bone Marrow Transplantation Therapy
    Start date: 2006-12-12

Other drugs received by patient: Methotrexate; Campath; Fludarabine Phosphate



Adverse event in 57 year old male receiving Sandimmune (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-10-25

Patient: 57 year old male

Adverse reactions / side effects: Hepatic Function Abnormal, Acute Graft Versus Host Disease, Renal Abscess, Rash, Lung Abscess, Aspergillosis, Sinus Tachycardia, Myocarditis Mycotic, Cardiac Hypertrophy, Blood Pressure Decreased

Adverse event resulted in: death

Suspect drug(s):
Sandimmune (Cyclosporine)

Other drugs received by patient: Endoxan; Methotrexate; Prograf; Thiotepa; Cyclophosphamide; Irradiation; Cellcept; Steroids NOS



Adverse event in 1 year old male receiving Sandimmune (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-10-17

Patient: 1 year old male, weighing 8.5 kg (18.7 pounds)

Adverse reactions / side effects: Stem Cell Transplant, Immunosuppressant Drug Level Decreased, Acute Graft Versus Host Disease, Acute Myeloid Leukaemia Recurrent

Adverse event resulted in: death

Suspect drug(s):
Neoral
    Dosage: unk, unk
    Administration route: Oral
    Indication: Bone Marrow Transplant
    End date: 2003-08-14

Sandimmune
    Dosage: 1.5 mg/kg
    Indication: Bone Marrow Transplant

Other drugs received by patient: Methotrexate; Endoxan



Adverse event in 43 year old male receiving Sandimmune (Cyclosporine)

Reported by a physician from Germany on 2007-10-15

Patient: 43 year old male, weighing 84.0 kg (184.8 pounds)

Adverse reactions / side effects: Mean Cell Haemoglobin Concentration Decreased, Blood Triglycerides Increased, Blood Cholesterol Increased, Condition Aggravated, Mean Cell Volume Increased, Blood Creatinine Increased, Hypertriglyceridaemia

Suspect drug(s):
Sandimmune (Cyclosporine)

Other drugs received by patient: Fumaderm



Adverse event in 12 year old male receiving Sandimmune (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-10-08

Patient: 12 year old male

Adverse reactions / side effects: Stomatitis, Acute Graft Versus Host Disease in Skin, Rash, Drug Level Decreased

Suspect drug(s):
Methotrexate

Sandimmune
    Dosage: 200 mg/day
    Indication: Stem Cell Transplant
    Start date: 2006-05-01
    End date: 2006-07-01

Other drugs received by patient: Fludarabine Phosphate; Melphalan



Adverse event in male receiving Sandimmune (Cyclosporine)

Reported by a consumer/non-health professional from Italy on 2007-10-05

Patient: male

Adverse reactions / side effects: Dermatitis, Pyrexia, Lipase Increased

Suspect drug(s):
Sandimmune (Cyclosporine)



Adverse event in receiving Sandimmune (Cyclosporine)

Reported by a consumer/non-health professional from Sweden on 2007-10-04

Patient:

Adverse reactions / side effects: Intentional Overdose, Suicide Attempt

Suspect drug(s):
Sandimmune (Cyclosporine)



Adverse event in male receiving Sandimmune (Cyclosporine)

Reported by a pharmacist from Germany on 2007-10-02

Patient: male

Adverse reactions / side effects: White Blood Cell Count Decreased, Cachexia, Immunosuppressant Drug Level Decreased, Renal Impairment, RED Blood Cell Count Decreased, Dialysis, Blood Albumin Decreased

Adverse event resulted in: hospitalization

Suspect drug(s):
Sandimmune (Cyclosporine)

Other drugs received by patient: Drug Therapy NOS



Adverse event in 1 year old male receiving Sandimmune (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-10-02

Patient: 1 year old male, weighing 8.5 kg (18.7 pounds)

Adverse reactions / side effects: Stem Cell Transplant, Immunosuppressant Drug Level Decreased, Acute Graft Versus Host Disease, Acute Myeloid Leukaemia Recurrent

Adverse event resulted in: death

Suspect drug(s):
Cyclosporine
    Administration route: Oral
    Indication: Bone Marrow Transplant

Sandimmune
    Dosage: 1.5 mg/kg
    Indication: Bone Marrow Transplant

Other drugs received by patient: Methotrexate



Adverse event in female receiving Sandimmune (Cyclosporine)

Reported by a physician from Spain on 2007-07-24

Patient: female

Adverse reactions / side effects: Anaphylactic Reaction, Rash, Erythema, Hypertension

Suspect drug(s):
Sandimmune (Cyclosporine)



Adverse event in 57 year old female receiving Sandimmune (Cyclosporine)

Reported by a physician from Croatia (Local Name: Hrvatska) on 2007-07-19

Patient: 57 year old female, weighing 75.5 kg (166.1 pounds)

Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Diabetes Mellitus, Cytomegalovirus Infection, Muscular Weakness

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Lescol XL
    Dosage: 80 mg, qd
    Administration route: Oral
    End date: 2007-04-12

Sandimmune
    Dosage: 150 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2007-02-17

Other drugs received by patient: Cellcept; Decortin; Nitrofurantoin; Lacidipine; Furosemide; Controloc; Cortef



Adverse event in 11 year old male receiving Sandimmune (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-07-18

Patient: 11 year old male, weighing 27.0 kg (59.4 pounds)

Adverse reactions / side effects: Neutrophilia, Leukocytosis

Suspect drug(s):
Neoral
    Indication: Renal Transplant

Neoral
    Dosage: 350 mg/d
    Administration route: Oral
    Start date: 2000-08-22

Sandimmune
    Dosage: unk, unk
    Indication: Renal Transplant
    End date: 2000-08-21

Other drugs received by patient: Solu-Medrol; Mizoribine; Valproate Sodium; Amlodipine; Kalimate; Medrol



Adverse event in 11 year old male receiving Sandimmune (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-07-18

Patient: 11 year old male, weighing 27.0 kg (59.4 pounds)

Adverse reactions / side effects: Neutrophilia, Leukocytosis

Suspect drug(s):
Neoral
    Indication: Renal Transplant

Neoral
    Dosage: 350 mg/d
    Administration route: Oral
    Start date: 2000-08-22

Sandimmune
    Dosage: unk, unk
    Indication: Renal Transplant
    End date: 2000-08-21

Other drugs received by patient: Solu-Medrol; Mizoribine; Valproate Sodium; Amlodipine; Kalimate; Medrol



Adverse event in male receiving Sandimmune (Cyclosporine)

Reported by a physician from Germany on 2007-07-18

Patient: male

Adverse reactions / side effects: Peroneal Nerve Palsy

Suspect drug(s):
Prograf
    Indication: Liver Transplant

Sandimmune
    Indication: Liver Transplant



Adverse event in male receiving Sandimmune (Cyclosporine)

Reported by a pharmacist from Germany on 2007-07-18

Patient: male

Adverse reactions / side effects: Renal Disorder, Metabolic Acidosis, Pneumonia, Nephropathy Toxic, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Sandimmune (Cyclosporine)

Other drugs received by patient: Cellcept; Fosamax; Acebutolol



Adverse event in 15 year old male receiving Sandimmune (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-07-17

Patient: 15 year old male, weighing 62.0 kg (136.4 pounds)

Adverse reactions / side effects: Therapeutic Response Decreased, Protein Urine Present, Glomerulosclerosis, Kidney Fibrosis, Nephropathy Toxic, Chronic Sinusitis, Nephritis, Nephrotic Syndrome

Suspect drug(s):
Neoral
    Dosage: 125 mg/day
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 2000-09-14
    End date: 2001-01-10

Neoral
    Dosage: 100 mg/day
    Administration route: Oral
    Start date: 2001-01-11
    End date: 2004-03-22

Neoral
    Dosage: 75 mg/day
    Administration route: Oral
    Start date: 2004-03-23
    End date: 2004-09-16

Neoral
    Dosage: 50 mg/day
    Administration route: Oral
    Start date: 2004-09-17
    End date: 2004-09-30

Neoral
    Dosage: 200 mg/day
    Administration route: Oral
    Start date: 2004-10-01
    End date: 2004-10-18

Neoral
    Dosage: 150 mg/day
    Administration route: Oral
    Start date: 2004-10-19
    End date: 2006-02-20

Neoral
    Dosage: 200 mg/day
    Administration route: Oral
    Start date: 2006-01-20
    End date: 2006-10-16

Neoral
    Dosage: 140 mg/day
    Administration route: Oral
    Start date: 2006-10-17
    End date: 2007-01-22

Neoral
    Dosage: 50 mg/day
    Administration route: Oral
    Start date: 2007-01-22
    End date: 2007-05-11

Neoral
    Dosage: 100 mg/day
    Administration route: Oral
    Start date: 2007-05-12

Sandimmune
    Dosage: 100 mg/day
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 2000-02-01

Sandimmune
    Dosage: 150 mg/day
    Administration route: Oral
    End date: 2000-09-13

Other drugs received by patient: Cellcept; Cellcept; Cellcept



Adverse event in 15 year old male receiving Sandimmune (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-07-13

Patient: 15 year old male, weighing 62.0 kg (136.4 pounds)

Adverse reactions / side effects: Therapeutic Response Decreased, Glomerulosclerosis, Kidney Fibrosis, Nephropathy Toxic, Nephrotic Syndrome

Suspect drug(s):
Neoral
    Dosage: 125 mg/day
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 2000-09-14
    End date: 2001-01-10

Neoral
    Dosage: 100 mg/day
    Administration route: Oral
    Start date: 2001-01-11
    End date: 2004-03-22

Neoral
    Dosage: 75 mg/day
    Administration route: Oral
    Start date: 2004-03-23
    End date: 2004-09-16

Neoral
    Dosage: 50 mg/day
    Administration route: Oral
    Start date: 2004-09-17
    End date: 2004-09-30

Neoral
    Dosage: 200 mg/day
    Administration route: Oral
    Start date: 2004-10-01
    End date: 2004-10-18

Neoral
    Dosage: 150 mg/day
    Administration route: Oral
    Start date: 2004-10-19
    End date: 2006-02-20

Neoral
    Dosage: 200 mg/day
    Administration route: Oral
    Start date: 2006-01-20
    End date: 2006-10-16

Neoral
    Dosage: 140 mg/day
    Administration route: Oral
    Start date: 2006-10-17
    End date: 2007-01-22

Neoral
    Dosage: 50 mg/day
    Administration route: Oral
    Start date: 2007-01-22
    End date: 2007-05-11

Neoral
    Dosage: 100 mg/day
    Administration route: Oral
    Start date: 2007-05-12

Sandimmune
    Dosage: 100 mg/day
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 2000-02-01

Sandimmune
    Dosage: 150 mg/day
    Administration route: Oral
    End date: 2000-09-13

Other drugs received by patient: Cellcept; Cellcept; Cellcept



Adverse event in 48 year old male receiving Sandimmune (Cyclosporine)

Reported by a physician from Germany on 2007-07-12

Patient: 48 year old male, weighing 80.0 kg (176.0 pounds)

Adverse reactions / side effects: Bile Duct Obstruction, Bile Duct Stent Insertion, Hepatitis C, Alanine Aminotransferase Increased, Cholestasis, Disease Progression, Hepatic Enzyme Increased, Liver Transplant, Renal Failure, Cholangitis, Aspartate Aminotransferase Increased, Liver Transplant Rejection, Endoscopic Retrograde Cholangiopancreatography, Hepatic Cirrhosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Sandimmune
    Dosage: 500 mg, bid
    Administration route: Oral
    Indication: Liver Transplant
    Start date: 2006-08-29
    End date: 2007-05-25

Sandimmune
    Dosage: 300 mg/day
    Administration route: Oral

Sandimmune
    Dosage: 275 mg/day
    Administration route: Oral

Sandimmune
    Indication: Liver Transplant
    Start date: 2006-08-13



Adverse event in male receiving Sandimmune (Cyclosporine)

Reported by a consumer/non-health professional from Germany on 2007-07-12

Patient: male

Adverse reactions / side effects: Accident, HIP Arthroplasty, Osteonecrosis, Impaired Healing, Femoral Neck Fracture

Suspect drug(s):
Certican
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Heart Transplant
    Start date: 2005-01-01

Sandimmune
    Dosage: unk, unk
    Start date: 2003-07-01



Adverse event in 30 year old female receiving Sandimmune (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-07-12

Patient: 30 year old female, weighing 41.0 kg (90.2 pounds)

Adverse reactions / side effects: Hypoventilation, Capillary Permeability Increased, Pain, Pyrexia, Liver Disorder, Hyperventilation, Malaise, Chest Pain, Pulmonary Congestion, Pleural Effusion, Tachypnoea, Immunosuppressant Drug Level Increased, Acute Respiratory Failure, Oxygen Saturation Decreased, White Blood Cell Count Decreased, Blood Pressure Increased, Dyspnoea, Chest Discomfort, Vomiting, Brain Natriuretic Peptide Increased

Adverse event resulted in: disablity

Suspect drug(s):
Cyclophosphamide
    Dosage: 2000 mg/day
    Indication: Stem Cell Transplant
    Start date: 2006-06-24

Cyclophosphamide
    Dosage: 400 mg/day
    End date: 2006-06-25

Irradiation
    Indication: Stem Cell Transplant

Sandimmune
    Dosage: 2.4 ml/day
    Indication: Stem Cell Transplant
    Start date: 2006-06-26
    End date: 2006-06-26

Sandimmune
    Dosage: 10 ml/day
    Start date: 2006-06-27
    End date: 2006-06-28

Sandimmune
    Dosage: 2.4 ml/day
    Start date: 2006-06-29
    End date: 2006-06-30

Sandimmune
    Dosage: 10 ml/day
    Start date: 2006-07-01
    End date: 2006-07-02

Sandimmune
    Dosage: 5 ml/day
    Start date: 2006-07-03
    End date: 2006-07-03

Sandimmune
    Dosage: 2.4 ml/day
    Start date: 2006-07-04
    End date: 2006-07-05

Sandimmune
    Dosage: 5 ml/day
    Start date: 2006-07-06
    End date: 2006-07-10

Other drugs received by patient: Solanax; Solanax; Solanax; Polymyxin B Sulfate; Takepron; Mycosyst; Iscotin; Ciprofloxacin; Mucodyne; Zovirax; Urso 250; Funguard; Funguard; Funguard; Funguard; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Acyclovir; Acyclovir; Meylon; Meylon; Meylon; Dexamethasone Sodium Phosphate; Zofran; Zofran; Zofran; Atarax; Atarax; Atarax; Atarax; Atarax; Atarax; Atarax; Glyceol; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Lasix; Lasix; Lasix; Lasix; Lasix; Lasix; Lasix; Lasix; Primperan INJ; Primperan INJ; Uromitexan; Uromitexan; Leuprolide Acetate; Omepral; Fluconazole; Adalat; Solu-Cortef; Solu-Cortef; Solu-Cortef; Solu-Cortef; Haptoglobin; Methotrexate; Methotrexate; Methotrexate; NEO-Minophagen C; Sulpyrine; Sulpyrine; Polyglobin / SPA /; Clindamycin Phosphate; Meropen; Meropen; Meropen; Pazucross; Pentagin



Adverse event in male receiving Sandimmune (Cyclosporine)

Reported by a consumer/non-health professional from Germany on 2007-07-12

Patient: male

Adverse reactions / side effects: Accident, HIP Arthroplasty, Osteonecrosis, Impaired Healing, Femoral Neck Fracture

Suspect drug(s):
Certican
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Heart Transplant
    Start date: 2005-01-01

Sandimmune
    Dosage: unk, unk
    Start date: 2003-07-01



Adverse event in male receiving Sandimmune (Cyclosporine)

Reported by a physician from Germany on 2007-07-12

Patient: male

Adverse reactions / side effects: Face Oedema

Suspect drug(s):
Diclofenac Sodium
    Indication: Back Pain

Sandimmune
    Indication: Renal Transplant
    Start date: 1992-01-01



Adverse event in 48 year old male receiving Sandimmune (Cyclosporine)

Reported by a physician from Germany on 2007-07-12

Patient: 48 year old male, weighing 80.0 kg (176.0 pounds)

Adverse reactions / side effects: Bile Duct Obstruction, Bile Duct Stent Insertion, Hepatitis C, Alanine Aminotransferase Increased, Cholestasis, Disease Progression, Hepatic Enzyme Increased, Liver Transplant, Renal Failure, Cholangitis, Aspartate Aminotransferase Increased, Liver Transplant Rejection, Endoscopic Retrograde Cholangiopancreatography, Hepatic Cirrhosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Sandimmune
    Dosage: 500 mg, bid
    Administration route: Oral
    Indication: Liver Transplant
    Start date: 2006-08-29
    End date: 2007-05-25

Sandimmune
    Dosage: 300 mg/day
    Administration route: Oral

Sandimmune
    Dosage: 275 mg/day
    Administration route: Oral

Sandimmune
    Indication: Liver Transplant
    Start date: 2006-08-13



 Page 1   Next >>

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009